Kelly Leanne 4
4 · GRI Bio, Inc. · Filed Sep 22, 2025
Insider Transaction Report
Form 4
Kelly Leanne
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-09-18+43,222→ 43,222 totalExercise: $1.93Exp: 2035-09-18→ Common Stock (43,222 underlying)
Footnotes (1)
- [F1]Options to purchase 29,923 shares vested in full upon the date of grant and options to purchase 13,299 shares will vest in 12 substantially equal quarterly installments such that the stock option is fully vested on the third anniversary of the date of grant.